149 related articles for article (PubMed ID: 25681745)
1. Spheronization of solid lipid extrudates: A novel approach on controlling critical process parameters.
Petrovick GF; Pein M; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 May; 92():15-21. PubMed ID: 25681745
[TBL] [Abstract][Full Text] [Related]
2. Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization.
Petrovick GF; Breitkreutz J; Pein-Hackelbusch M
Int J Pharm; 2016 Jun; 506(1-2):361-70. PubMed ID: 27132502
[TBL] [Abstract][Full Text] [Related]
3. Spheronization of solid lipid extrudates: Elucidation of spheroid formation mechanism.
Petrovick GF; Breitkreutz J
Eur J Pharm Biopharm; 2018 Apr; 125():148-158. PubMed ID: 29407224
[TBL] [Abstract][Full Text] [Related]
4. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
Krause J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
[TBL] [Abstract][Full Text] [Related]
5. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
6. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
Yan X; He H; Meng J; Zhang C; Hong M; Tang X
Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
[TBL] [Abstract][Full Text] [Related]
7. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
[TBL] [Abstract][Full Text] [Related]
8. Taste masked lipid pellets with enhanced release of hydrophobic active ingredient.
Vaassen J; Bartscher K; Breitkreutz J
Int J Pharm; 2012 Jun; 429(1-2):99-103. PubMed ID: 22465412
[TBL] [Abstract][Full Text] [Related]
9. Use of extrusion aids for successful production of Kollidon
Loka NC; Saripella KK; Pinto CA; Neau SH
Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of pellets using Avicel CL611 as spheronization aid.
Puah SY; Yap HN; Chaw CS
Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process.
Trivedi NR; Rajan MG; Johnson JR; Shukla AJ
Crit Rev Ther Drug Carrier Syst; 2007; 24(1):1-40. PubMed ID: 17430098
[TBL] [Abstract][Full Text] [Related]
13. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
Karim S; Baie SH; Hay YK; Bukhari NI
Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
[TBL] [Abstract][Full Text] [Related]
15. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
Chatchawalsaisin J; Podczeck F; Newton JM
Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the co-extrudability and spheronization properties of wet masses.
Pinto JF; Lameiro MH; Martins P
Int J Pharm; 2001 Oct; 227(1-2):71-80. PubMed ID: 11564542
[TBL] [Abstract][Full Text] [Related]
17. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
Güres S; Siepmann F; Siepmann J; Kleinebudde P
Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
[TBL] [Abstract][Full Text] [Related]
18. Characterization of laminar extrudates manufactured at room temperature in the absence of solvents for the delivery of drugs.
Oliveira G; Wahl MA; Pinto JF
Int J Pharm; 2013 Sep; 454(1):90-8. PubMed ID: 23845856
[TBL] [Abstract][Full Text] [Related]
19. An Extrusion Spheronization Approach to Enable a High Drug Load Formulation of a Poorly Soluble Drug with a Low Melting Surfactant.
Tatavarti A; Kesisoglou F
J Pharm Sci; 2015 Nov; 104(11):3752-3759. PubMed ID: 26205160
[TBL] [Abstract][Full Text] [Related]
20. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
Krueger C; Thommes M
Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
